Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis
Status: | Recruiting |
---|---|
Conditions: | Orthopedic |
Therapuetic Areas: | Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 1/17/2019 |
Start Date: | March 2016 |
End Date: | April 2021 |
Contact: | Paul Arnold, MD |
Email: | parnold@kumc.edu |
Phone: | (913) 588-7587 |
A Multi-Center, Prospective, Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis
The aim of this study is to compare outcomes and cost-effectiveness of anterior versus
posterior surgical treatment for lumbar Isthmic Spondylolisthesis. The primary objective is
to compare treatment effectiveness in terms of functional outcomes as measured by Oswestry
Disability Index (ODI) v2.1a and to compare safety outcomes measured by treatment-related
adverse events. Secondary objectives are to compare treatments in terms of differences in
pain, quality of life, health utilities, and need for re-operation. Finally, a
cost-effectiveness analysis will be performed. This analysis will take the form of
cost-effectiveness if there is a difference in treatment effects or cost-minimization if
there is no difference in treatment efficacy.
posterior surgical treatment for lumbar Isthmic Spondylolisthesis. The primary objective is
to compare treatment effectiveness in terms of functional outcomes as measured by Oswestry
Disability Index (ODI) v2.1a and to compare safety outcomes measured by treatment-related
adverse events. Secondary objectives are to compare treatments in terms of differences in
pain, quality of life, health utilities, and need for re-operation. Finally, a
cost-effectiveness analysis will be performed. This analysis will take the form of
cost-effectiveness if there is a difference in treatment effects or cost-minimization if
there is no difference in treatment efficacy.
Inclusion Criteria:
- Aged 18 to 80 years, inclusive
- Grade I, II or III (less than 75% slip of the cephalad vertebra compared to the caudal
vertebra) isthmic spondylolisthesis at single level between L4 and S1
- Unresponsive to a minimum of 3 months of non-surgical treatment
- No previous surgical treatment for isthmic spondylolisthesis
- Patients who are medically suitable for surgical management
- Patients who have consented for surgical treatment
- Willing and able to comply with the Investigational Protocol (IP)
- Informed Consent Form (ICF) signed by patient
Exclusion Criteria:
- Any previous lumbar spine surgery
- Patient has significant scoliosis (Cobb angle is greater than 25 degrees)
- Subject has cauda equina syndrome defined as neural compression causing neurogenic
bowel (rectal incontinence) or bladder (bladder retention or incontinence) dysfunction
- Subject is pregnant or of child-bearing potential and not currently on adequate birth
control method
- Active infection at the surgical site
- Recent history (less than 1 year) of chemical substance dependency or significant
psychosocial disturbance that may impact the outcome or study participation, in the
opinion of the Investigator
- Pre-existent neurologic or mental disorder which would preclude accurate evaluation
and follow-up (i.e. Alzheimer's disease, Parkinson's disease, unstable psychiatric
disorder with hallucinations and/or delusions or schizophrenia
- Participation in another clinical trial of drug or device within the past 30 days that
could influence the outcomes of this study
- Is a prisoner
- Acquired immune deficiency syndrome (AIDS) or AIDS-related complex
- Active malignancy or history of invasive malignancy within the last five years, with
the exception of superficial basal cell carcinoma or squamous cell carcinoma of the
skin that has been definitely treated; patients with carcinoma in situ of the uterine
cervix treated definitely more than 1 year prior to enrollment may enter the study
We found this trial at
13
sites
3400 N Charles St
Baltimore, Maryland 21205
Baltimore, Maryland 21205
410-516-8000
Principal Investigator: Daniel Sciubba, MD
Phone: 410-955-4424
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
Click here to add this to my saved trials
9500 Euclid Avenue
Cleveland, Ohio 44106
Cleveland, Ohio 44106
216.444.2200
Principal Investigator: Thomaz Mroz
Phone: 216-445-9232
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
Click here to add this to my saved trials
22 S Greene St
Baltimore, Maryland 21201
Baltimore, Maryland 21201
(410) 328-8667
Principal Investigator: Steven Ludwig, MD
Phone: 410-328-8808
University of Maryland Medical Center Founded in 1823 as the Baltimore Infirmary, the University of...
Click here to add this to my saved trials
Charlottesville, Virginia 22908
Principal Investigator: Christopher Shaffrey, MD
Phone: 434-243-9331
Click here to add this to my saved trials
University of Missouri T he University of Missouri was founded in 1839 in Columbia, Mo.,...
Click here to add this to my saved trials
Kansas City, Kansas
Principal Investigator: Sarah Woodrow, MD
Phone: 913-588-6122
Click here to add this to my saved trials
1020 Walnut St
Philadelphia, Pennsylvania 19107
Philadelphia, Pennsylvania 19107
(215) 955-6000
Principal Investigator: James Harrop, MD
Phone: 215-955-7000
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19107
Principal Investigator: Alexander Vaccaro, MD, PhD
Phone: 267-339-3578
Click here to add this to my saved trials
Saint Louis, Missouri 63110
Principal Investigator: Wilson Zack Ray, MD
Phone: 314-362-9959
Click here to add this to my saved trials
590 Wakara Way
Salt Lake City, Utah 84108
Salt Lake City, Utah 84108
Principal Investigator: Darrel Brodke, MD
Phone: 801-587-5450
Click here to add this to my saved trials
Click here to add this to my saved trials
5300 Tallman Ave NW
Seattle, Washington 98122
Seattle, Washington 98122
(206) 782-2700
Principal Investigator: Jens Chapman
Phone: 206-731-3466
Swedish Medical Center Since 1910, Swedish has been the region's hallmark for excellence in health...
Click here to add this to my saved trials
Toronto, Ontario
Principal Investigator: Michael Fehlings, MD, PhD
Phone: (416) 603-5627
Click here to add this to my saved trials